Literature DB >> 1625015

Aneurysm recurrence following endovascular balloon occlusion.

C B Heilman1, E S Kwan, J K Wu.   

Abstract

Endovascular balloon occlusion is an alternative treatment for surgically unclippable cerebral aneurysms. The results of aneurysm occlusion with either a silicone or a latex balloon in a common carotid artery bifurcation aneurysm model are compared to determine which type of balloon was least likely to result in aneurysm recurrence. Five rabbits each underwent endovascular balloon occlusion with either a silicone or a latex balloon, with seven rabbits serving as controls. At 3 months postocclusion, nine of the 10 balloon-treated aneurysms had recurred. The recurrent aneurysm tended to be larger in animals treated with silicone than with latex balloons. A dense fibrotic response was present around the collar of the latex balloons, but no significant fibrotic response was found in the silicone balloon group. This study suggests that with currently available balloons, the initial complete angiographic obliteration of an aneurysm following balloon occlusion should not be interpreted as a cure and that periodic follow-up angiography should be performed.

Entities:  

Mesh:

Year:  1992        PMID: 1625015     DOI: 10.3171/jns.1992.77.2.0260

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

Review 1.  Endoluminal scaffolds for vascular reconstruction and exclusion of aneurysms from the cerebral circulation.

Authors:  Baruch B Lieber; Chander Sadasivan
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

2.  Flow modification in canine intracranial aneurysm model by an asymmetric stent: studies using digital subtraction angiography (DSA) and image-based computational fluid dynamics (CFD) analyses.

Authors:  Yiemeng Hoi; Ciprian N Ionita; Rekha V Tranquebar; Kenneth R Hoffmann; Scott H Woodward; Dale B Taulbee; Hui Meng; Stephen Rudin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2006-03-13

3.  Endovascular treatment of ACom intracranial aneurysms. Report on series of 280 patients.

Authors:  S Finitsis; R Anxionnat; A Lebedinsky; P C Albuquerque; M F Clayton; L Picard; S Bracard
Journal:  Interv Neuroradiol       Date:  2010-03-25       Impact factor: 1.610

4.  Nascent aneurysm formation at the basilar terminus induced by hemodynamics.

Authors:  Ling Gao; Yiemeng Hoi; Daniel D Swartz; John Kolega; Adnan Siddiqui; Hui Meng
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

5.  Are the configuration and neck morphology of experimental aneurysms predictable? A technical approach.

Authors:  R Thiex; W Möller-Hartmann; F J Hans; K Scherer; T Krings
Journal:  Neuroradiology       Date:  2004-05-15       Impact factor: 2.804

6.  Assessment of experimental saccular aneurysm using selective angiography in common carotid artery of rabbits.

Authors:  Dong Woo Chang; Bong Kyung Kim; Jae Hoon Shin; Young Min Yoon; Seung Hyun Oh; Yeo Sung Yoon; Sung-Hyeok Hong; Ki Chang Lee; Young Won Lee; Kang Moon Seo; Oh-Kyeong Kweon; Jung Hee Yoon; Nam-Shik Shin; Kyu Ho Lee; Jun-Gyo Suh; Je Kyung Seong
Journal:  Anat Cell Biol       Date:  2010-06-30

7.  High-concentration ethylene-vinyl alcohol copolymer and endovascular treatment of experimental aneurysms: feasibility of embolization without protection devices at the neck.

Authors:  Jean Raymond; Igor Salazkin; Annick Metcalfe; François Guilbert; Alain Weill; Daniel Roy
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 8.  Experimental saccular aneurysms. I. Review of surgically-constructed models and their laboratory applications.

Authors:  T F Massoud; G Guglielmi; C Ji; F Viñuela; G R Duckwiler
Journal:  Neuroradiology       Date:  1994-10       Impact factor: 2.804

Review 9.  Complications of elastase-induced arterial saccular aneurysm in rabbits: case reports and literature review.

Authors:  Jason S Villano; Christine A Boehm; Elizabeth L Carney; Timothy K Cooper
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.